These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 15024962

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neurodegenerative movement disorders: the contribution of functional imaging.
    Piccini P.
    Curr Opin Neurol; 2004 Aug; 17(4):459-66. PubMed ID: 15247543
    [Abstract] [Full Text] [Related]

  • 4. [Imaging of dopamine transporter with Tc99m-Trodat-SPECT in movement disorders].
    Kanyó B, Argyelán M, Dibó G, Szakonyi Z, Vécsei L, Fülöp F, Láncz A, Forgács P, Pávics L.
    Ideggyogy Sz; 2003 Jul 20; 56(7-8):231-40. PubMed ID: 12971118
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Functional neuroimaging in movement disorders].
    Borbély K.
    Orv Hetil; 2001 Oct 28; 142(43):2347-55. PubMed ID: 11760452
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S, Antke C, Müller HW.
    Behav Brain Res; 2009 Dec 01; 204(1):1-31. PubMed ID: 19523490
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular imaging of movement disorders.
    Lizarraga KJ, Gorgulho A, Chen W, De Salles AA.
    World J Radiol; 2016 Mar 28; 8(3):226-39. PubMed ID: 27029029
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Functional imaging of neurotransmitter systems in movement disorders.
    Ilgin N.
    Q J Nucl Med; 1998 Sep 28; 42(3):179-92. PubMed ID: 9796366
    [Abstract] [Full Text] [Related]

  • 17. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G.
    Brain; 1997 Mar 28; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. SPECT and PET imaging of the dopaminergic system in Parkinson's disease.
    Brücke T, Djamshidian S, Bencsits G, Pirker W, Asenbaum S, Podreka I.
    J Neurol; 2000 Sep 28; 247 Suppl 4():IV/2-7. PubMed ID: 11199811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.